Ionis Pharmaceuticals (NASDAQ: IONS) reported Q1 EPS of ($0.46), $0.24 better than the analyst estimate of ($0.70). Revenue for the quarter came in at $142 million versus the consensus estimate of $125.21 million.

For earnings history and earnings-related data on Ionis Pharmaceuticals (IONS) click here.